New York State Common Retirement Fund Sigilon Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.74 - $1.64 $4,926 - $10,917	-6,657 Reduced 97.9%	143 $0
Q1 2022 May 05, 2022	SELL	$1.24 - $3.03 $152 - $372	-123 Reduced 1.78%	6,800 $10,000
Q4 2021 Feb 02, 2022	BUY	$2.58 - $6.13 $129 - $306	50 Added 0.73%	6,923 $19,000
Q3 2021 Nov 02, 2021	BUY	$4.42 - $10.61 $44 - $106	10 Added 0.15%	6,873 $39,000
Q2 2021 Aug 02, 2021	BUY	$9.15 - $20.17 $36,371 - $80,175	3,975 Added 137.64%	6,863 $74,000
Q1 2021 May 11, 2021	BUY	$18.76 - $40.91 $54,178 - $118,148	2,888 New	2,888 $65,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.